An interventional study of biopsy in Thyroid Cancer, sponsored by SB Istanbul Education and Research Hospital. Status unknown at 1 site in Turkey. Open to participants aged 17 Years to 85 Years. Per ClinicalTrials.gov, last updated 2012-01-19.
Sponsored by SB Istanbul Education and Research Hospital · Not applicable, Interventional, and Diagnostic
Evaluation of the effectivity of the new thyroid fine needle aspiration biopsy (FNAB) apparatus of which patented from Turkish Patent Institute.
The author group of this investigation produced a new thyroid fine needle aspiration biopsy (FNAB) apparatus and patented it from Turkish patent Institute. FNAB indicated nodular goitre patients are the subjects of this research. First, the investigators will perform standart FNAB after this procedure will perform FNAB with new apparatus. The investigators will evaluate the aspirates according to number of cells and malignity ratio of cells.
967 studies on the registry are indexed under Thyroid Diseases; 197 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 544 interventional studies indexed under Thyroid Diseases.
Browse Thyroid Diseases studies →SB Istanbul Education and Research Hospital is the lead sponsor of 19 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
FNAB will be perform first with standart technique and after with new FNAB apparatus
Procedure: biopsy
fnab
Also known as: fnab
number of cells
number of aspirated cells will be compared
Time frame: 2
type of cells
type (benign, suspect, malign) of cells will be compared
Time frame: 2
This study is status unknown, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SB Istanbul Education and Research Hospital